Track topics on Twitter Track topics that are important to you
NeoImmuneTech, Inc., an immunotherapy drug development company focused on advanced cancer treatments, today announced the U.S. Food and Drug Administration (FDA) approved i...
NeoImmuneTech, Inc., an immunotherapy drug development company focused on advanced cancer treatments, today announced the appointment of NgocDiep (‘Diep’) Le, M.D., Ph....
-- Studies in B cell and T cell lymphoma models suggest Hyleukin-7 can significantly enhance and prolong CAR-T activity -- NeoImmuneTech, Inc., an immunotherapy drug de...
Genexine, a clinical stage biotechnology company developing innovative biologics, and its spin-off company in the US, NeoImmuneTech, Inc. (NIT), today announced that Hyleukin-7, t...
NeoImmuneTech, a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, HyLeukin-7, in the US and EU. Base...
NeoImmuneTech (NIT), a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, Hyleukin-7, in the U.S. and ...
We have published hundreds of NeoImmuneTech news stories on BioPortfolio along with dozens of NeoImmuneTech Clinical Trials and PubMed Articles about NeoImmuneTech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeoImmuneTech Companies in our database. You can also find out about relevant NeoImmuneTech Drugs and Medications on this site too.